Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04505371 · ClinicalTrials.gov registry record · NA

Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV

A NA study of HIV Infections and Smoking Cessation, sponsored by Seattle Institute for Biomedical and Clinical Research.

Active
Registry status
NA
Development phase
226
Enrollment target
1
Study location

NCT04505371: Active NA study of HIV Infections and Smoking Cessation, sponsored by Seattle Institute for Biomedical and Clinical Research.

NCT04505371 is a NA study of HIV Infections and Smoking Cessation that is active but no longer recruiting, run by Seattle Institute for Biomedical and Clinical Research. The registered enrollment target is 226 participants, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04505371, a NA study of HIV Infections and Smoking Cessation, is active but no longer recruiting, sponsored by Seattle Institute for Biomedical and Clinical Research.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
226 participants
Enrollment target
1
Study location

Study Summary

This project will compare the effectiveness of an HIV-specific comprehensive wellness intervention designed to have broad appeal to smokers living with HIV to the effectiveness of standard care services that include referral to the National VA Quitline and SmokefreeVET texting program. Participants in both arms will have access to pharmacotherapy available through their Veterans Affairs (VA) healthcare providers.

Primary Outcome

Self-reported smoking abstinence at 6-month follow-up. To assess disconfirmation rates, abstinence will be biochemically confirmed via saliva cotinine among a random subset of people reporting tobacco abstinence. In this subset, abstinence will be defined by a negative reading on the Alere iScreen saliva dipstick, which uses a cut-point of \<30 ng/ml cotinine to indicate no nicotine exposure.

Conditions Studied

HIV Infections Smoking Cessation Smoking

Interventions

  • BEHAVIORAL Wellness Intervention for Smokers with HIV

Study Locations (1)

Washington

  • VA Puget Sound Health Care System Seattle Division - Seattle

Trial Details

FieldValue
Enrollment Target 226 participants
Start Date 2021-06-04
Est. Completion 2026-02-28
Phase NA
Seattle Institute for Biomedical and Clinical Research

43 total trials

What the registry record for NCT04505371 still lists

NCT04505371 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 445-participant average among 542 other HIV Infections trials with a reported enrollment target (49% lower).

The record links to 3 conditions, with HIV Infections appearing as the primary indexed condition, and to 1 intervention - of which Wellness Intervention for Smokers with HIV is the first listed.

NCT04505371 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT04505371 about?

NCT04505371 is a clinical study titled "Improving the Reach & Effectiveness of Smoking Cessation Services Targeted to Veterans Living With HIV". This project will compare the effectiveness of an HIV-specific comprehensive wellness intervention designed to have broad appeal to smokers living with HIV to the effectiveness of standard care services that include referral to the National VA Quitline and SmokefreeVET texting program. Participants ...

What is the current status of trial NCT04505371?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 226 participants. The study started on 2021-06-04. Estimated completion is 2026-02-28.

What conditions does trial NCT04505371 study?

This clinical trial studies the following conditions: HIV Infections, Smoking Cessation, Smoking.

What interventions are being tested in trial NCT04505371?

The interventions under investigation include: Wellness Intervention for Smokers with HIV (BEHAVIORAL).

Who is sponsoring clinical trial NCT04505371?

This trial is sponsored by Seattle Institute for Biomedical and Clinical Research, which has 43 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04505371 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04505371's enrollment target sits among peer trials

226 157th of 542 higher than 386 of 542 other HIV Infections trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04419272 · 226 participants · Phase 4

    Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

  • NCT05449002 · 226 participants · NA

    Digital Single Session Intervention for Youth Mental Health

  • NCT05488054 · 226 participants · NA

    Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery

  • NCT05924477 · 226 participants · NA

    Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Related registry views

Source: ClinicalTrials.gov NCT04505371, the US trial registry maintained by the National Library of Medicine. NCT04505371 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.